RGS22
(Regulator of G-Protein Signaling 22 (RGS22))
Protein Region
N-Term
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-RGS22 antibody (Catalog #: ARP55320_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
RGS22
(Regulator of G-Protein Signaling 22 (RGS22))
Synonymes
PRTD-NY2 Peptide, RGD1565493 Peptide, regulator of G protein signaling 22 Peptide, regulator of G-protein signaling 22 Peptide, regulator of G-protein signalling 22 Peptide, RGS22 Peptide, Rgs22 Peptide
Sujet
RGS22 inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form.
Alias Symbols: DKFZp434I092, FLJ40080, FLJ75004, MGC102908, PRTD-NY2